Literature DB >> 10593863

Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK.

H Haase1, T Podzuweit, G Lutsch, A Hohaus, S Kostka, C Lindschau, M Kott, R Kraft, I Morano.   

Abstract

A novel calcium channel-associated protein of approximately 700 kDa has been identified in mammalian cardiomyocytes that undergoes substantial cAMP-dependent protein kinase (PKA) phosphorylation. It was therefore designated as phosphoprotein 700 (pp700). The pp700 interacts specifically with the beta(2) subunit of cardiac L-type calcium channels as revealed by coprecipitation experiments using affinity-purified antibodies against different calcium channel subunits. It is surprising that amino acid sequence analysis of pig pp700 revealed homology to AHNAK-encoded protein, which was originally identified in human cell lines of neural crest origin as 700-kDa phosphoprotein. Cardiac AHNAK expression was assessed on mRNA level by reverse transcriptase-polymerase chain reaction. Sequence-directed antibodies raised against human AHNAK recognized pp700 in immunoblotting and immunoprecipitation experiments, confirming the homology between both proteins. Anti-AHNAK antibodies labeled preferentially the plasma membrane of cardiomyocytes in cryosections of rat cardiac tissue and isolated cardiomyocytes. Sarcolemmal pp700/AHNAK localization was not influenced by stimulation of either the PKA or the protein kinase C pathway. In back-phosphorylation studies with cardiac biopsies, we identified distinct pp700 pools. The membrane-associated fraction of pp700 underwent substantial in vivo phosphorylation on beta-adrenergic receptor stimulation by isoproterenol, whereas the cytoplasmic fraction of pp700 was not accessible to endogenous PKA. It is important that in vivo phosphorylation occurred in that pp700 fraction which coprecipitated with the calcium channel beta subunit. We hypothesize that both phosphorylation of pp700 and its coupling to the beta subunit play a physiological role in cardiac beta-adrenergic signal transduction. Haase, H., Podzuweit, T., Lutsch, G., Hohaus, A., Kostka, S., Lindschau, C., Kott, M., Kraft, R., Morano, I. Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target that has similarities to AHNAK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593863     DOI: 10.1096/fasebj.13.15.2161

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

1.  Modulation of the smooth-muscle L-type Ca2+ channel alpha1 subunit (alpha1C-b) by the beta2a subunit: a peptide which inhibits binding of beta to the I-II linker of alpha1 induces functional uncoupling.

Authors:  A Hohaus; M Poteser; C Romanin; N Klugbauer; F Hofmann; I Morano; H Haase; K Groschner
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 2.  The ß subunit of voltage-gated Ca2+ channels.

Authors:  Zafir Buraei; Jian Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

3.  Dynamic interactions between L-type voltage-sensitive calcium channel Cav1.2 subunits and ahnak in osteoblastic cells.

Authors:  Ying Shao; Kirk J Czymmek; Patricia A Jones; Victor P Fomin; Kamil Akanbi; Randall L Duncan; Mary C Farach-Carson
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-04       Impact factor: 4.249

4.  The beta subunit of voltage-gated Ca2+ channels interacts with and regulates the activity of a novel isoform of Pax6.

Authors:  Yun Zhang; Yoichi Yamada; Mingming Fan; Saroja D Bangaru; Bochao Lin; Jian Yang
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

5.  Ahnak1 is a tuneable modulator of cardiac Ca(v)1.2 calcium channel activity.

Authors:  Ines Pankonien; Julio L Alvarez; Anke Doller; Clemens Köhncke; Dana Rotte; Vera Regitz-Zagrosek; Ingo Morano; Hannelore Haase
Journal:  J Muscle Res Cell Motil       Date:  2011-10-29       Impact factor: 2.698

Review 6.  Translational research and therapeutic perspectives in dysferlinopathies.

Authors:  Florian Barthélémy; Nicolas Wein; Martin Krahn; Nicolas Lévy; Marc Bartoli
Journal:  Mol Med       Date:  2011-05-06       Impact factor: 6.354

7.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

8.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07

9.  The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells.

Authors:  Akihiko Komuro; Yutaka Masuda; Koichi Kobayashi; Roger Babbitt; Murat Gunel; Richard A Flavell; Vincent T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

10.  Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.

Authors:  Yanchao Huang; Antoine de Morrée; Alexandra van Remoortere; Kate Bushby; Rune R Frants; Johan T den Dunnen; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2008-03-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.